{"id":"organoid-drug-screen","type":"method","name_en":"Organoid drug screening","name_zh":"类器官药物筛选","aliases":["organoid drug screen","drug screen"],"description":{"en":"Library items include an automated, personalised GBM tumor-organoid drug-screening platform, and DELPHAI (preprint) which models temozolomide responses in GBM organoids.","zh":"文献库收录自动化、个体化的 GBM 肿瘤类器官药物筛选平台，以及模拟 GBM 类器官替莫唑胺反应的 DELPHAI（预印本）。"},"externalIds":{},"graphNames":["organoid drug screen"],"mentions":{"items":["VC0097"],"topics":["perturbation-gbm-therapy"]},"evidenceRefs":["VC0097","VC0129"],"reviewStatus":"draft","version":"0.1.0","page_url":"https://gliostate.com/entities/organoid-drug-screen/","page_url_zh":"https://gliostate.com/zh/entities/organoid-drug-screen/","api_url":"https://gliostate.com/api/entities/organoid-drug-screen.json","external_links":[],"source_file":"https://gliostate.com/data/entities/organoid-drug-screen.json","evidence_items":[{"id":"VC0097","title":"Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.","year":"2026","page_url":"https://gliostate.com/library/VC0097/","api_url":"https://gliostate.com/api/items/VC0097.json"},{"id":"VC0129","title":"DELPHAI, AI Agent for Predicting Drug Response and Resistance","year":"2025","page_url":"https://gliostate.com/library/VC0129/","api_url":"https://gliostate.com/api/items/VC0129.json"}],"mentioned_in_items":[{"id":"VC0097","title":"Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.","year":"2026","page_url":"https://gliostate.com/library/VC0097/","api_url":"https://gliostate.com/api/items/VC0097.json"}],"mentioned_in_topics":[{"id":"perturbation-gbm-therapy","title_en":"Perturbation data for glioblastoma: radiotherapy, drugs and CRISPR","title_zh":"胶质母细胞瘤扰动数据：放疗、药物与 CRISPR","url":"https://gliostate.com/perturbations/gbm-therapy-perturbations/","api_url":"https://gliostate.com/api/topics/perturbation-gbm-therapy.json"}],"relations":[{"subject":"organoid-drug-screen","subject_name_en":"Organoid drug screening","subject_name_zh":"类器官药物筛选","predicate":"associated_with","object":"gbm-organoid","object_name_en":"Patient-derived GBM organoids","object_name_zh":"患者来源 GBM 类器官","confidence":"high","evidence":[{"id":"VC0097","role":"supports","title":"Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.","page_url":"https://gliostate.com/library/VC0097/","api_url":"https://gliostate.com/api/items/VC0097.json"}],"note":null,"sources":[{"kind":"topic","id":"perturbation-gbm-therapy","url":"https://gliostate.com/perturbations/gbm-therapy-perturbations/","api_url":"https://gliostate.com/api/topics/perturbation-gbm-therapy.json"}]}],"related_entities":[{"id":"gbm-organoid","type":"model","name_en":"Patient-derived GBM organoids","name_zh":"患者来源 GBM 类器官","page_url":"https://gliostate.com/entities/gbm-organoid/","page_url_zh":"https://gliostate.com/zh/entities/gbm-organoid/","api_url":"https://gliostate.com/api/entities/gbm-organoid.json","via":"relation"},{"id":"glioblastoma","type":"disease","name_en":"Glioblastoma (GBM)","name_zh":"胶质母细胞瘤（GBM）","page_url":"https://gliostate.com/entities/glioblastoma/","page_url_zh":"https://gliostate.com/zh/entities/glioblastoma/","api_url":"https://gliostate.com/api/entities/glioblastoma.json","via":"co-mention"},{"id":"crispri","type":"method","name_en":"CRISPR interference (CRISPRi)","name_zh":"CRISPR 干扰（CRISPRi）","page_url":"https://gliostate.com/entities/crispri/","page_url_zh":"https://gliostate.com/zh/entities/crispri/","api_url":"https://gliostate.com/api/entities/crispri.json","via":"co-mention"},{"id":"delphai","type":"model","name_en":"DELPHAI","name_zh":"DELPHAI","page_url":"https://gliostate.com/entities/delphai/","page_url_zh":"https://gliostate.com/zh/entities/delphai/","api_url":"https://gliostate.com/api/entities/delphai.json","via":"co-mention"},{"id":"lincs-l1000","type":"dataset","name_en":"LINCS L1000 drug signatures","name_zh":"LINCS L1000 药物特征谱","page_url":"https://gliostate.com/entities/lincs-l1000/","page_url_zh":"https://gliostate.com/zh/entities/lincs-l1000/","api_url":"https://gliostate.com/api/entities/lincs-l1000.json","via":"co-mention"},{"id":"perturb-seq","type":"method","name_en":"Perturb-seq","name_zh":"Perturb-seq（扰动单细胞测序）","page_url":"https://gliostate.com/entities/perturb-seq/","page_url_zh":"https://gliostate.com/zh/entities/perturb-seq/","api_url":"https://gliostate.com/api/entities/perturb-seq.json","via":"co-mention"},{"id":"radiotherapy","type":"method","name_en":"Radiotherapy","name_zh":"放射治疗","page_url":"https://gliostate.com/entities/radiotherapy/","page_url_zh":"https://gliostate.com/zh/entities/radiotherapy/","api_url":"https://gliostate.com/api/entities/radiotherapy.json","via":"co-mention"},{"id":"replogle-genome-scale-perturb-seq","type":"dataset","name_en":"Genome-scale Perturb-seq (K562/RPE1)","name_zh":"全基因组规模 Perturb-seq（K562/RPE1）","page_url":"https://gliostate.com/entities/replogle-genome-scale-perturb-seq/","page_url_zh":"https://gliostate.com/zh/entities/replogle-genome-scale-perturb-seq/","api_url":"https://gliostate.com/api/entities/replogle-genome-scale-perturb-seq.json","via":"co-mention"}]}